Merozan

Meropenem, the active ingredient in Merozan, is a carbapenem presented as an injectable solution for intravenous use. It is employed to treat severe bacterial infections in hospitalized patients, including intra‑abdominal infections, hospital‑acquired pneumonia, and sepsis. The drug is active against a broad range of Gram‑negative and Gram‑positive organisms, including strains resistant to other β‑lactam antibiotics.

GNH USA supplies Merozan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across EU and global markets.

Merozan (meropenem) is used for serious bacterial infections where broad‑spectrum coverage is required.

- Severe bacterial infections: provides rapid bactericidal activity to control life‑threatening infections. - Complicated intra‑abdominal infections: eradicates mixed aerobic and anaerobic pathogens after surgical intervention. - Hospital‑acquired pneumonia: treats ventilator‑associated and other nosocomial pneumonias caused by resistant organisms. - Sepsis: delivers systemic antimicrobial effect to support hemodynamic stabilization in septic patients.

Like all antibiotics, meropenem may cause adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Headache: transient and usually resolves without intervention. - Infusion site reactions: erythema, pain, or phlebitis at the injection site.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disorders. - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Clostridioides difficile‑associated diarrhea: can lead to colitis and requires prompt treatment.

Prior to initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential complications.

- Renal function: adjust dose in patients with impaired renal clearance. - Hypersensitivity: avoid in individuals with known carbapenem allergy. - Seizure risk: monitor closely in patients with a history of seizures or CNS disease. - Pregnancy: use only when the potential benefit justifies the potential risk to the fetus. - Concomitant valproic acid: may increase the risk of seizures; consider alternative therapy. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Meropenem can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Valproic acid: may increase the risk of seizures. - Probenecid: reduces renal excretion of meropenem, raising plasma levels. - High‑dose aminoglycosides: additive nephrotoxicity.

Moderate Interactions (Monitor Closely): - Diuretics: may affect renal clearance of meropenem. - Other nephrotoxic agents (e.g., vancomycin): monitor kidney function. - Oral contraceptives: possible reduction in contraceptive effectiveness; advise additional contraceptive measures.